Cheryl A. Thompson
BETHESDA, MD 15 October 2013—Nephron Pharmaceuticals Corporation on October 11 announced a recall of 10 lots of the company's 0.083% albuterol sulfate inhalation solution "as a precautionary measure."
The lots are A3A33A, A3A33B, A3A34A, A3A35A, A3A36A, A3A37A, A3A38A, A3A40A, A3A41A, and A3A42A.
Nephron said the 10 lots passed the quality specifications at the time of manufacture and no "reportable" adverse drug events for any of those lots have been received.
In the announcement, Nephron said it was undertaking the recall in accordance with FDA's guidance (PDF) regarding simulation of the aseptic processing operation.
Consumers who have albuterol solution from any of the 10 lots are being asked by the company to dispose of the units.
For questions, comments, or
more information on this
article, please contact the
ASHP News Center at email@example.com.
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814